Prelude Therapeutics
Clinical trials sponsored by Prelude Therapeutics, explained in plain language.
-
New hope for tough blood cancers: experimental drug PRT2527 enters human testing
Disease control CompletedThis early-stage study tested a new drug called PRT2527 in 86 people with blood cancers like lymphoma and leukemia that had returned or stopped responding to standard treatments. The main goals were to find a safe dose and see if the drug works, both alone and combined with other…
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
New targeted drug shows promise for hard-to-treat cancers
Disease control CompletedThis early-stage study tested a new drug, PRT3789, in 135 people with advanced solid tumors that have a specific genetic change (SMARCA4 mutation). The drug was given alone or with chemotherapy (docetaxel) to see if it is safe and what dose works best. The goal is to find a dose …
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Jun 01, 2026 18:08 UTC